Risk assessment for acute kidney injury and death among new COVID-19 positive adult patients without chronic kidney disease: retrospective cohort study among three US hospitals.

ABSTRACT:

Objective

To develop simple but clinically informative risk stratification tools using a few top demographic factors and biomarkers at COVID-19 diagnosis to predict acute kidney injury (AKI) and death.

Design

Retrospective cohort analysis, follow-up from 1 February through 28 May 2020.

Setting

3 teaching hospitals, 2 urban and 1 community-based in the Boston area.

Participants

Eligible patients were at least 18 years old, tested COVID-19 positive from 1 February through 28 May 2020, and had at least two serum creatinine measurements within 30 days of a new COVID-19 diagnosis. Exclusion criteria were having chronic kidney disease or having a previous AKI within 3 months of a new COVID-19 diagnosis.

Main outcomes and measures

Time from new COVID-19 diagnos

SUBMITTER: Li D 

PROVIDER: S-EPMC8861883 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature